Why insider trading matters?

What separates FormWhispers.com from others is that we created it to meet our own needs and we use it everyday to make better investment decisions. We will keep improving it to serve us better and to serve you better.

- Founders of FormWhispers.com
Mirati Therapeutics, Inc. (MRTX)
Sector: Healthcare; Industry: Biotechnology

Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company is involved in developing sitravatinib, a spectrum-selective kinase inhibitor, which is in Phase II clinical for the treatment of non-small cell lung cancer (NCSLC); and in Phase Ib clinical trial to treat NCSLC patients with Casitas B-lineage Lymphoma genetic alterations, as well as KRAS G12C inhibitor program for NSCLC adenocarcinoma patients, colorectal cancer patients, and other cancers.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-05 CARTER BRUCE L A Director Sell 2,250 $177.11 $398,507 Yes
2021-03-19 Hickey Benjamin EVP, Chief Commercial Officer Sell 2,369 $176.44 $417,978 Yes
2021-03-10 Braslyn Ltd. 10%-Owner Sell 12,381 $197.64 $2,446,924 Yes
2021-03-05 Boxer Capital, LLC 10%-Owner Sell 400,005 $181.15 $72,460,905 Yes
2021-03-02 Cherrington Julie M Director Sell 2,000 $201.01 $402,020 No
2021-02-02 Faga Daniel EVP, Chief Operating Officer Sell 1,340 $194.38 $260,469 Yes
2021-02-02 CARTER BRUCE L A Director Sell 2,250 $191.12 $430,018 Yes
2021-01-29 Martinez Maria E Director Sell 7,500 $203.54 $1,526,584 Yes
2021-01-21 Johnson Craig A Director Sell 15,000 $211.55 $3,173,203 Yes
2021-01-07 REED VICKIE S SVP, Chief Accounting Officer Sell 779 $212.23 $165,325 No
2021-01-07 Hickey Benjamin EVP, Chief Commercial Officer Sell 2,078 $216.33 $449,525 No
2021-01-06 Christensen Jamie EVP, Chief Scientific Officer Sell 1,459 $210.39 $306,961 No
2021-01-07 Faga Daniel EVP, Chief Operating Officer Sell 2,625 $216.33 $567,854 No
2021-01-06 BAUM CHARLES M President & CEO Sell 4,511 $210.39 $949,066 No
2020-12-18 BAUM CHARLES M President & CEO Sell 40,000 $234.48 $9,379,114 Yes
2020-12-15 FUCHS HENRY J Director Sell 10,000 $233.39 $2,333,907 Yes
2020-12-14 CARTER BRUCE L A Director Sell 2,250 $246.28 $554,127 Yes
2020-12-14 GREY MICHAEL G Director Sell 10,900 $245.44 $2,675,345 Yes
2020-10-30 Boxer Capital, LLC 10%-Owner Sell 400,000 $202.00 $80,800,000 Yes
2020-10-29 Braslyn Ltd. 10%-Owner Sell 400,000 $208.34 $83,334,437 Yes
2020-08-11 CARTER BRUCE L A Director Sell 2,250 $126.41 $284,428 Yes
2020-08-10 FUCHS HENRY J Director Sell 10,000 $131.38 $1,313,783 Yes
2020-06-12 Braslyn Ltd. 10%-Owner Sell 600,000 $97.00 $58,200,000 Yes
2020-06-12 Braslyn Ltd. 10%-Owner Sell 600,000 $69.00 $41,400,000 Yes
2020-05-18 CARTER BRUCE L A Director Sell 4,000 $106.86 $427,440 Yes
2020-05-11 CHEN ISAN EVP, Chief Medical Officer Sell 33,334 $105.00 $3,500,070 Yes
2020-04-20 Johnson Craig A Director Sell 15,000 $93.00 $1,395,000 Yes
2020-04-17 BAUM CHARLES M President & CEO Sell 40,000 $90.33 $3,613,109 Yes
2020-01-10 Boxer Capital, LLC 10%-Owner Buy 50,000 $97.50 $4,875,000 No
2019-12-23 Christensen Jamie EVP, Chief Scientific Officer Sell 6,666 $125.00 $833,250 Yes

Insider Smart

SYSCO CORP (SYY) - PELTZ NELSON and Frank Joshua D are insiders of SYSCO CORP, check their transactions to see how they sell high and buy low. Would that be more persuasive than just buy or sell?